Meta-analysis: the impact of IL28B polymorphisms on rapid and sustained virological response in HCV-2 and -3 patients
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Meta-analysis: the impact of IL28B polymorphisms on rapid and sustained virological response in HCV-2 and -3 patients
Authors
Keywords
-
Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 36, Issue 4, Pages 353-362
Publisher
Wiley
Online
2012-06-29
DOI
10.1111/j.1365-2036.2012.05197.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C
- (2011) G. Fattovich et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- IL28B rs12979860 C/T polymorphism in elderly chronic hepatitis C patients treated with pegylated-interferon and ribavirin
- (2011) E. G. Giannini et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Importance of Host Genetic Factors HLA and IL28B as Predictors of Response to Pegylated Interferon and Ribavirin
- (2011) Paloma Muñoz de Rueda et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Ultra-Rapid Virological Response, Young Age, Low γ-GT/ALT-Ratio, and Absence of Steatosis Identify a Subgroup of HCV Genotype 3 Patients Who Achieve SVR with IFN-α2a Monotherapy
- (2011) Ahmad Amanzada et al. DIGESTIVE DISEASES AND SCIENCES
- A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus
- (2011) Philippe Halfon et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- IL28Bgenetic variation and treatment response in patients with hepatitis C virus genotype 3 infection
- (2011) Amir Moghaddam et al. HEPATOLOGY
- Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C
- (2011) Davide Bitetto et al. HEPATOLOGY
- Hepatic steatosis in chronic hepatitis C patients infected with genotype 2 is associated with insulin resistance, hepatic fibrosis and affects cumulative positivity of serum hepatitis C virus RNA in peginterferon and ribavirin combination therapy
- (2011) Yoshito Itoh et al. HEPATOLOGY RESEARCH
- IL-28B predicts response to chronic hepatitis C therapy - fine-mapping and replication study in Asian populations
- (2011) H. Ochi et al. JOURNAL OF GENERAL VIROLOGY
- IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C
- (2011) P.-Y. Bochud et al. JOURNAL OF HEPATOLOGY
- ‘Easy to treat’ genotypes were not created equal: Can rapid virological response (RVR) level the playing field?
- (2011) Andres Duarte-Rojo et al. JOURNAL OF HEPATOLOGY
- Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: A meta-analysis
- (2011) Pierre Deltenre et al. JOURNAL OF HEPATOLOGY
- IL28B single nucleotide polymorphisms in the treatment of hepatitis C
- (2011) Christian M. Lange et al. JOURNAL OF HEPATOLOGY
- Interleukin 28B Gene Variation at rs12979860 Determines Early Viral Kinetics During Treatment in Patients Carrying Genotypes 2 or 3 of Hepatitis C Virus
- (2011) Magnus Lindh et al. JOURNAL OF INFECTIOUS DISEASES
- Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b
- (2011) Naoya Sakamoto et al. JOURNAL OF MEDICAL VIROLOGY
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of IL28B Genotype on the Early and Sustained Virologic Response in Treatment-Naïve Patients With Chronic Hepatitis C
- (2010) Albert Friedrich Stättermayer et al. Clinical Gastroenterology and Hepatology
- An IL28B Polymorphism Determines Treatment Response of Hepatitis C Virus Genotype 2 or 3 Patients Who Do Not Achieve a Rapid Virologic Response
- (2010) Alessandra Mangia et al. GASTROENTEROLOGY
- Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus
- (2010) Alexander J. Thompson et al. GASTROENTEROLOGY
- Hepatic ISG Expression Is Associated With Genetic Variation in Interleukin 28B and the Outcome of IFN Therapy for Chronic Hepatitis C
- (2010) Masao Honda et al. GASTROENTEROLOGY
- Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study
- (2010) Andri Rauch et al. GASTROENTEROLOGY
- Interferon-Induced Gene Expression Is a Stronger Predictor of Treatment Response Than IL28B Genotype in Patients With Hepatitis C
- (2010) Michael T. Dill et al. GASTROENTEROLOGY
- IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C
- (2010) Thomas J. Urban et al. HEPATOLOGY
- Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes
- (2010) Marco Antonio Montes-Cano et al. HEPATOLOGY
- Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients
- (2010) Ming-Lung Yu et al. HEPATOLOGY
- Insights into the role of interferon lambda in hepatitis C virus infection
- (2010) Heidi Barth JOURNAL OF HEPATOLOGY
- Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin
- (2010) Thomas-Matthias Scherzer et al. JOURNAL OF HEPATOLOGY
- Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients
- (2010) Christoph Sarrazin et al. JOURNAL OF HEPATOLOGY
- Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b
- (2010) Tomokazu Kawaoka et al. JOURNAL OF HEPATOLOGY
- Cell-Type Specific Gene Expression Signature in Liver Underlies Response to Interferon Therapy in Chronic Hepatitis C Infection
- (2009) Limin Chen et al. GASTROENTEROLOGY
- Shortened treatment duration in treatment-naive genotype 1 HCV patients with rapid virological response: A meta-analysis
- (2009) Christophe Moreno et al. JOURNAL OF HEPATOLOGY
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- Interferon-alfa, interferon-λ and hepatitis C
- (2009) Thomas R O'Brien NATURE GENETICS
- IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
- (2009) Vijayaprakash Suppiah et al. NATURE GENETICS
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
- (2009) Yasuhito Tanaka et al. NATURE GENETICS
- Interferon signaling and treatment outcome in chronic hepatitis C
- (2008) M. Sarasin-Filipowicz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More